Ivan Spasojevic, PhD

Publications

Batinic-Haberle, I., A. Tovmasyan, and I. Spasojevic. “The complex mechanistic aspects of redox-active compounds, commonly regarded as SOD mimics.” Bioinorganic Reaction Mechanisms 9, no. 1–4 (December 1, 2013): 35–58. https://doi.org/10.1515/irm-2013-0004.

Full Text

Tovmasyan, Artak, Tin Weitner, Huaxin Sheng, MiaoMiao Lu, Zrinka Rajic, David S. Warner, Ivan Spasojevic, Julio S. Reboucas, Ludmil Benov, and Ines Batinic-Haberle. “Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology..” Inorganic Chemistry 52, no. 10 (May 6, 2013): 5677–91. https://doi.org/10.1021/ic3012519.

PMID
23646875
Full Text

Weitner, Tin, Ivan Kos, Huaxin Sheng, Artak Tovmasyan, Julio S. Reboucas, Ping Fan, David S. Warner, Zeljko Vujaskovic, Ines Batinic-Haberle, and Ivan Spasojevic. “Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+..” Free Radical Biology & Medicine 58 (May 2013): 73–80. https://doi.org/10.1016/j.freeradbiomed.2013.01.006.

PMID
23328731
Full Text

Tovmasyan, Artak, Huaxin Sheng, Tin Weitner, Amanda Arulpragasam, Miaomiao Lu, David S. Warner, Zeljko Vujaskovic, Ivan Spasojevic, and Ines Batinic-Haberle. “Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators..” Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre 22, no. 2 (January 2013): 103–30. https://doi.org/10.1159/000341715.

PMID
23075911
Full Text

Jin, Genglin, Zachary J. Reitman, Christopher G. Duncan, Ivan Spasojevic, David M. Gooden, B Ahmed Rasheed, Rui Yang, et al. “Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas..” Cancer Research 73, no. 2 (January 2013): 496–501. https://doi.org/10.1158/0008-5472.CAN-12-2852.

PMID
23204232
Full Text

Reitman, Zachary J., Bryan D. Choi, Ivan Spasojevic, Darell D. Bigner, John H. Sampson, and Hai Yan. “Enzyme redesign guided by cancer-derived IDH1 mutations..” Nature Chemical Biology 8, no. 11 (November 2012): 887–89. https://doi.org/10.1038/nchembio.1065.

PMID
23001033
Full Text

Spasojevic, Ivan, Ligia R. S. da Costa, Mitchell E. Horwitz, Gwynn D. Long, Keith M. Sullivan, John P. Chute, Cristina Gasparetto, Ashley Morris, Nelson J. Chao, and David A. Rizzieri. “Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry..” Cancer Investigation 30, no. 9 (November 2012): 679–82. https://doi.org/10.3109/07357907.2012.726386.

PMID
23020519
Full Text

Il’yasova, Dora, Peter Scarbrough, and Ivan Spasojevic. “Urinary biomarkers of oxidative status..” Clinica Chimica Acta; International Journal of Clinical Chemistry 413, no. 19–20 (October 2012): 1446–53. https://doi.org/10.1016/j.cca.2012.06.012.

PMID
22683781
Full Text

Wu, Jing, Guorong Li, Coralia Luna, Ivan Spasojevic, David L. Epstein, and Pedro Gonzalez. “Endogenous production of extracellular adenosine by trabecular meshwork cells: potential role in outflow regulation..” Investigative Ophthalmology & Visual Science 53, no. 11 (October 2012): 7142–48. https://doi.org/10.1167/iovs.12-9968.

PMID
22997289
Full Text

Il’yasova, Dora, Frances Wang, Ivan Spasojevic, Karel Base, Ralph B. D’Agostino, and Lynne E. Wagenknecht. “Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI..” Obesity (Silver Spring, Md.) 20, no. 10 (October 2012): 2147–50. https://doi.org/10.1038/oby.2012.170.

PMID
22836686
Full Text

Pages